Related Experiment Video
Updated: May 11, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Rotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies
Anupam Mukherjee1, Mamta Chawla-Sarkar
1Division of Virology, National Institute of Cholera and Enteric Diseases, P-33, C.I.T. Road, Scheme-XM, Beliaghata, Kolkata, 700010 West Bengal India.
Insights
Rotavirus, a leading cause of severe diarrhea in young children, can be prevented with newly developed vaccines. Ongoing surveillance and vaccine development are crucial for global child health.
Area of Science:
- Pediatrics
- Infectious Diseases
- Vaccinology
Background:
- Acute diarrhea remains a significant global cause of mortality in young children.
- Rotaviruses are identified as the primary infectious agent responsible for 40-50% of severe acute diarrhea cases worldwide.
- Rotavirus disease leads to over 600,000 deaths and 2.4 million hospitalizations annually, particularly in South-East Asia and sub-Saharan Africa.
Purpose of the Study:
- To review the impact of rotavirus disease on child mortality.
- To discuss the current landscape of rotavirus vaccines, including licensed products and those in development.
- To emphasize the importance of surveillance and genetic analysis for vaccine efficacy and strain monitoring.
Main Methods:
- Review of existing literature on rotavirus epidemiology and disease burden.
- Analysis of licensed rotavirus vaccines (Rotarix and RotaTeq) and their characteristics.
- Discussion of third-generation vaccine candidates and the role of ongoing surveillance.
Main Results:
- Two safe and effective rotavirus vaccines are licensed globally, though vaccine uptake varies.
- Rotarix and RotaTeq target common rotavirus serotypes, significantly reducing disease morbidity where widely used.
- Third-generation vaccines, including inactivated virus and virus-like particle vaccines, are under development.
Conclusions:
- Rotavirus vaccines have demonstrated a significant decrease in disease morbidity.
- Continuous surveillance of circulating rotavirus strains is essential for assessing vaccine effectiveness and monitoring new strains.
- Integrating rotavirus vaccines into national immunization programs can substantially reduce child mortality, especially in low-resource settings.
Abstract:
For centuries, acute diarrhea has been a major cause of death in young children worldwide, and until 1973, before rotavirus was discovered; no infectious agents could be identified in about 80% of patients admitted to hospital with severe dehydrating diarrhea. Rotaviruses have now been shown to cause 40-50% of severe acute diarrhea in young children worldwide in both developing and developed countries. More than 600,000 young children die and approximately 2.4 million hospitalize annually from rotavirus disease, especially in South-East Asia and sub-Saharan Africa. Two safe and effective vaccines are now licensed in 100 countries but used in 17 countries. Rotarix (GSK) vaccine is derived from single attenuated human rotavirus G1P[8], representative of the most common serotype identified worldwide. RotaTeq (Merck) is a pentavalent mixture of naturally attenuated bovine/human rotavirus reassortants representing G1, G2, G3, G4, and P[8] serotypes. Though these vaccines have already dramatically decreased the morbidity associated with rotavirus in countries where they are widely used, the third generation of vaccines, based on inactivated viruses or recombinant virus like particle are already in pipeline. Continuous surveillance and the genetic and antigenic analysis of the various strains of rotavirus circulating worldwide will aid significantly in assessing the effectiveness of these vaccines and monitor emergence of new strains. Introduction of rotavirus vaccines in national vaccine policy along with other childhood vaccines may result in significant reduction in mortality in children in poor socioeconomic countries.
Related Concept Videos
Size and Structure of Viral Genomes
Human Virome
Bacterial Gastroenteritis
Microorganisms in Medicine and Therapeutics
Viruses with RNA Genomes
Infectious Diseases and Their Occurrence

